Biopharma Week in Review Shrugging Off Constant Bad News; LLY Winning Obesity Drug Race
With pharma tariffs now expected by June and federal health agencies’ prospects looking worse, we may be close to peak negativity, but too much...
353 Views
Biopharma Week in Review - December 16, 2024
LLY partnered GLP-1 access with telehealth Ro and presented oral SERD data in breast cancer, rattling HIMS, LFMD, ARVN, and OLMA.
315 Views
Biopharma Week in Review - December 9, 2024
We review last week’s biopharma news for meaningful clinical data, regulatory updates, research innovation, and M&A. Last week, BIOA discontinued...
376 Views
Biopharma Week in Review - July 15, 2024
We review last week’s biopharma news for meaningful clinical data, regulatory updates, research innovation, and M&A.
344 Views
Primer: uniQure NV (QURE US) - Sep 2025
uniQure is a pioneering gene therapy company with one approved product, HEMGENIX®, for Hemophilia B, which is the first and only gene therapy...
309 Views